BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30485682)

  • 1. iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer.
    Jiang Z; Zhang C; Gan L; Jia Y; Xiong Y; Chen Y; Wang Z; Wang L; Luo H; Li J; Zhu R; Ji X; Yu Q; Wang L
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800038. PubMed ID: 30485682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers that involved in the epigenetic transcriptional regulation for detection gastric cancer by iTRAQ based quantitative proteomic analysis.
    Jiang Z; Sun X; Zhang Q; Ji X; Yu Q; Huang T; Chen D; Chen H; Mei X; Wang L; He L; Fang J; Hou L; Wang L
    Clin Chim Acta; 2017 Aug; 471():29-37. PubMed ID: 28502558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
    Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
    J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer.
    Jiang Z; Shen H; Tang B; Yu Q; Ji X; Wang L
    Clin Chim Acta; 2017 Jan; 464():148-154. PubMed ID: 27884752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment.
    Kageyama S; Hanada E; Ii H; Tomita K; Yoshiki T; Kawauchi A
    Biomed Res Int; 2015; 2015():345219. PubMed ID: 26339607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors.
    Takemura K; Kawachi H; Eishi Y; Kitagaki K; Negi M; Kobayashi M; Uchida K; Inoue J; Inazawa J; Kawano T; Board PG
    Hum Pathol; 2014 Feb; 45(2):331-41. PubMed ID: 24342434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer.
    Jiang Z; Wei C; Luo Y; Xiao Y; Wang L; Guo W; Yuan X
    J Clin Lab Anal; 2022 Oct; 36(10):e24692. PubMed ID: 36098904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer.
    Zhang W; Chen L; Xiang H; Hu C; Shi W; Dong P; Lv W
    BMC Biochem; 2016 Dec; 17(1):19. PubMed ID: 27905872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
    Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
    Wei C; Xie J; Yuan X; Luo Y; Xiao Y; Liao W; Jiang Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24718. PubMed ID: 36181311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.
    Qie S; Chu C; Li W; Wang C; Sang N
    J Cell Biochem; 2014 Mar; 115(3):498-509. PubMed ID: 24122876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting GLS1 to cancer therapy through glutamine metabolism.
    Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y
    Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of biomarkers for gastric cancer: a proteomics approach.
    Lin LL; Huang HC; Juan HF
    J Proteomics; 2012 Jun; 75(11):3081-97. PubMed ID: 22498886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells.
    Li J; Li X; Wu L; Pei M; Li H; Jiang Y
    Cell Biol Int; 2019 Aug; 43(8):921-930. PubMed ID: 31115975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy.
    Kageyama S; Ii H; Taniguchi K; Kubota S; Yoshida T; Isono T; Chano T; Yoshiya T; Ito K; Yoshiki T; Kawauchi A; Nakata S
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaminase (GLS1) gene expression in primary breast cancer.
    Vidula N; Yau C; Rugo HS
    Breast Cancer; 2023 Nov; 30(6):1079-1084. PubMed ID: 37679553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling.
    Yoshikawa S; Nagao M; Toh R; Shinohara M; Iino T; Irino Y; Nishimori M; Tanaka H; Satomi-Kobayashi S; Ishida T; Hirata KI
    Am J Physiol Heart Circ Physiol; 2022 May; 322(5):H749-H761. PubMed ID: 35275762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer.
    Song Z; Wei B; Lu C; Li P; Chen L
    Oncol Lett; 2017 Sep; 14(3):3117-3123. PubMed ID: 28928849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.